Period
2004 - 2005
Number
2
Co-Authors
The topoisomerase I inhibitor DX-8951f is a poor substrate for the breast cancer resistance protein (2005)
Hattum, A.H. Van, Hoogsteen, I.J., Schlüper, H.M.M., Maliepaard, M., Scheffer, G.L., Scheper, R.J., ...
Induction of breast cancer resistance protein by the camptothecin derivative DX-895f is associated with minor reduction of antitumour activity (2004)